This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Cost-Effectiveness of Revascularization Strategies: The ASCERT Study

Tuesday, January 6, 2015

Submitted by


Source Name: Journal of the American College of Cardiology


Zugui Zhang; Paul Kolm; Maria V. Grau-Sepulveda; Angelo Ponirakis; Sean M. O’Brien; Lloyd W. Klein; Richard E. Shaw; Charles McKay; David M. Shahian; Frederick L. Grover; John E. Mayer; Kirk N. Garratt; Mark Hlatky; Fred H. Edwards; William S. Weintraub

In 2012 the American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT) compared the 5 year effectiveness of CABG versus PCI. The registry data is now linked with Centeres for Meidcare and Medicaid Services Claims data in order to study the long-term cost-effectiveness of the two strategies. The authors found that the life-time incremental cost-effectiveness ratio of CABG versus PCI was approximately $30,000/QALY gained, a value that is generally considered economically attractive.

Add comment

Log in or register to post comments